Monocyte-macrophage polarization balance in pre-diabetic individuals

Acta Diabetologica

Volumn 50, Issue 6, 2013, Pages 977-982

  Fadini, Gian Paolo ^a,b,c   Cappellari, Roberta ^c   Mazzucato, Marta ^a   Agostini, Carlo ^a,c   Vigili De Kreutzenberg, Saula ^a   Avogaro, Angelo ^a,c  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

Atherosclerosis; Diabetes; Innate immunity

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTI INFLAMMATORY M2 CELL; ANTIGEN EXPRESSION; ARTICLE; CARDIOVASCULAR RISK; CELLULAR PARAMETERS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; MIDDLE AGED; MONOCYTE; MONOCYTE MACROPHAGE POLARIZATION BALANCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PRO INFLAMMATORY M1 CELL; WAIST CIRCUMFERENCE;

ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOOD CELL COUNT; CARDIOVASCULAR DISEASES; CELL POLARITY; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; PREDIABETIC STATE; RECEPTORS, IGG; RISK FACTORS;

EID: 84890496495     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-013-0517-3     Document Type: Article

References (16)

1. Grundy SM (2012) Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 59(7):635-643
2. Sabanayagam C, Shankar A, Lim SC, Lee J, Tai ES, Wong TY (2011) Serum C-reactive protein level and prediabetes in two Asian populations. Diabetologia 54(4):767-775
3. Gerstein HC, Werstuck GH (2013) Dysglycaemia, vasculopenia and the chronic consequences of diabetes. Lancet Diabetes Endocrinol 1(71):77
4. Mantovani A, Garlanda C, Locati M (2009) Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 29(10):1419-1423
5. Nagareddy PR, Murphy AJ, Stirzaker RA, Hu Y, Yu S, Miller RG, Ramkhelawon B, Distel E, Westerterp M, Huang LS, Schmidt AM, Orchard TJ, Fisher EA, Tall AR, Goldberg IJ (2013) Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab 17(5):695-708
6. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116(16):e74-e80
7. + monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography. J Am Coll Cardiol 60(16):1512-1520
8. Fadini GP, de Kreutzenberg SV, Boscaro E, Albiero M, Cappellari R, Krankel N, Landmesser U, Toniolo A, Bolego C, Cignarella A, Seeger F, Dimmeler S, Zeiher A, Agostini C, Avogaro A (2013) An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. Diabetologia 56(8):1856-1866
9. Fadini GP, Marcuzzo G, Marescotti MC, de Kreutzenberg SV, Avogaro A (2012) Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general population. Acta Diabetol 49(6):445-451
10. Dushkin MI (2012) Macrophage/foam cell is an attribute of inflammation: mechanisms of formation and functional role. Biochemistry (Mosc) 77(4):327-338
11. Bernal-Lopez MR, Llorente-Cortes V, Calleja F, Lopez-Carmona D, Mayas MD, Gomez-Huelgas R, Badimon L, Tinahones FJ (2011) Effect of different degrees of impaired glucose metabolism on the expression of inflammatory markers in monocytes of patients with atherosclerosis. Acta Diabetol. doi: 10.1007/s00592-011-0337-2
12. Cheng DW, Jiang Y, Shalev A, Kowluru R, Crook ED, Singh LP (2006) An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells. Arch Physiol Biochem 112(4-5):189-218
13. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195-2207
14. Fadini GP, Albiero M, Boscaro E, Menegazzo L, Cabrelle A, Piliego T, Federici M, Agostini C, Avogaro A (2010) Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells. Cell Biol Int 34(7):709-715
15. Onat A, Can G, Cicek G, Ayhan E, Dogan Y, Kaya H (2011) Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults. Acta Diabetol. doi: 10.1007/s00592-011-0313-x
16. Tall AR, Yvan-Charvet L, Westerterp M, Murphy AJ (2012) Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis. Arterioscler Thromb Vasc Biol 32(11):2547-2552